BioVie(BIVI) - 2024 Q1 - Quarterly Report

(Mark One) For the quarterly period ended: September 30, 2023 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Fair Value Measurements at June 30, 2023 You are cautioned not to place undue reliance on the forward-looking statements in this report, which speak only as of the date of this report. Ex ...